Annual Statements Open main menu

MAXIMUS, INC. - Quarter Report: 2023 June (Form 10-Q)

Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark one)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________to__________.
Commission file number: 1-12997
Maximus_logo_2022.jpg

Maximus, Inc.
(Exact name of registrant as specified in its charter)
Virginia54-1000588
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
1600 Tysons Boulevard, McLean, Virginia
22102
(Address of principal executive offices)
(Zip Code)
(703) 251-8500
(Registrant's telephone number, including the area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, no par valueMMSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒
 
Accelerated filer ☐
 
Non-accelerated filer ☐
Smaller reporting company ☐
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
There were 60,783,621 shares of the registrant's Common Stock outstanding as of July 31, 2023.


Table of Contents
Table of Contents to Third Quarter 2023 Form 10-Q

2

Table of Contents
Unless otherwise specified, references in this Quarterly Report on Form 10-Q to "our," "we," "us," "Maximus," the "Company," and "our business" refer to Maximus, Inc. and its subsidiaries.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Included in this Quarterly Report on Form 10-Q are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "opportunity," "could," "potential," "believe," "project," "estimate," "expect," "continue," "forecast," "strategy," "future," "likely," "may," "should," "will," and similar references to future periods.
Forward-looking statements that are not historical facts, including statements about our confidence, strategies and initiatives, and our expectations about revenues, results of operations, profitability, liquidity, market demand, the residual impacts of the coronavirus ("COVID-19") global pandemic, and our recent acquisitions, are forward-looking statements that are subject to risks and uncertainties. These risks could cause our actual results to differ materially from those indicated by such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
a failure to meet performance requirements could lead to penalties, liquidated damages, actual damages, adverse settlement agreements, and/or contract termination;
our failure to successfully bid for and accurately price contracts to generate our desired profit;
the effects of future legislative or government budgetary and spending changes;
the impact of the Biden Administration on federal procurement, federal funding to states' safety-net programs, and the overall decision-making process related to our industry, including our business and customers;
our ability to manage our growth, including acquired businesses;
difficulties in integrating or achieving projected revenues, earnings, and other benefits associated with acquired businesses;
the outcome of reviews or audits, which might result in financial penalties and impair our ability to respond to invitations for new work;
our ability to manage capital investments and startup costs incurred before receiving related contract payments;
our ability to manage our debt;
our ability to maintain technology systems and otherwise protect confidential or protected information;
our discovery of additional information related to the previously disclosed cybersecurity incident and any potential legal, business, reputational, or financial consequences resulting from the incident;
our ability to attract and retain executive officers, senior managers, and other qualified personnel to execute our business;
the ability of government customers to terminate contracts on short notice, with or without cause;
our ability to maintain relationships with key government entities from whom a substantial portion of our revenue is derived;
a failure to comply with laws governing our business, which might result in the Company being subject to fines, penalties, suspension, debarment, and other sanctions;
the costs and outcome of litigation;
the effects of changes in laws and regulations governing our business, including tax laws and applicable interpretations and guidance thereunder, or changes in accounting policies, rules, methodologies, and practices, and our ability to estimate the impact of such changes;
matters related to businesses we disposed of or divested; and
other factors set forth in Item 1A, "Risk Factors" of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on November 22, 2022.

Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise.
3

Table of Contents
PART I - Financial Information
Item 1. Financial Statements
Maximus, Inc.
Consolidated Statements of Operations
(Unaudited)
 For the Three Months EndedFor the Nine Months Ended
 June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(in thousands, except per share amounts)
Revenue$1,188,677 $1,125,785 $3,644,775 $3,453,987 
Cost of revenue924,313 915,564 2,907,061 2,787,160 
Gross profit264,364 210,221 737,714 666,827 
Selling, general, and administrative expenses182,545 132,974 471,445 387,502 
Amortization of intangible assets23,431 22,690 70,599 67,951 
Operating income58,388 54,557 195,670 211,374 
Interest expense21,026 10,791 63,631 29,867 
Other expense/(income), net1,005 2,497 (79)2,093 
Income before income taxes36,357 41,269 132,118 179,414 
Provision for income taxes5,494 9,934 29,472 44,653 
Net income$30,863 $31,335 $102,646 $134,761 
Earnings per share:
Basic$0.50 $0.51 $1.68 $2.17 
Diluted$0.50 $0.51 $1.67 $2.17 
Weighted average shares outstanding:
Basic61,141 61,607 61,125 62,038 
Diluted61,544 61,756 61,368 62,190 
Dividends declared per share$0.28 $0.28 $0.84 $0.84 
See accompanying notes to consolidated financial statements.
4

Table of Contents

Maximus, Inc.
Consolidated Statements of Comprehensive Income
(Unaudited)
 For the Three Months EndedFor the Nine Months Ended
 June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(in thousands)
Net income$30,863 $31,335 $102,646 $134,761 
Other comprehensive income/(loss), net of tax:
Foreign currency translation adjustments1,946 (8,935)10,947 (8,499)
Net (losses)/gains on cash flow hedge, net of tax effect of $2,513, $1,085, $(466), and $5,857, respectively
7,046 3,042 (1,297)16,416 
Other comprehensive income/(loss)8,992 (5,893)9,650 7,917 
Comprehensive income$39,855 $25,442 $112,296 $142,678 
See accompanying notes to consolidated financial statements.
5

Table of Contents
Maximus, Inc.
Consolidated Balance Sheets
(in thousands)
June 30, 2023September 30, 2022
(unaudited)
Assets:
Cash and cash equivalents$35,007 $40,658 
Accounts receivable, net798,509 807,110 
Income taxes receivable34,435 2,158 
Prepaid expenses and other current assets128,085 182,387 
Total current assets996,036 1,032,313 
Property and equipment, net44,808 52,258 
Capitalized software, net88,007 58,740 
Operating lease right-of-use assets160,563 132,885 
Goodwill1,780,884 1,779,415 
Intangible assets, net727,956 804,904 
Deferred contract costs, net45,928 47,732 
Deferred compensation plan assets44,412 37,050 
Deferred income taxes5,771 4,970 
Other assets48,819 42,447 
Total assets$3,943,184 $3,992,714 
Liabilities and Shareholders' Equity:
Liabilities:
Accounts payable and accrued liabilities$283,686 $264,553 
Accrued compensation and benefits140,007 178,199 
Deferred revenue, current portion64,822 87,146 
Income taxes payable70 718 
Long-term debt, current portion86,901 63,458 
Operating lease liabilities, current portion53,385 63,999 
Other current liabilities54,430 116,374 
Total current liabilities683,301 774,447 
Deferred revenue, non-current portion14,860 21,414 
Deferred income taxes207,145 206,099 
Long-term debt, non-current portion1,223,133 1,292,483 
Deferred compensation plan liabilities, non-current portion47,363 40,210 
Operating lease liabilities, non-current portion120,766 86,175 
Other liabilities13,763 22,515 
Total liabilities2,310,331 2,443,343 
Commitments and contingencies (Note 11)
Shareholders' equity:
Common stock, no par value; 100,000 shares authorized; 60,784 and 60,774 shares issued and outstanding as of June 30, 2023, and September 30, 2022, respectively
581,338 557,978 
Accumulated other comprehensive loss(24,311)(33,961)
Retained earnings1,075,826 1,025,354 
Total shareholders' equity1,632,853 1,549,371 
Total liabilities and shareholders' equity$3,943,184 $3,992,714 
See accompanying notes to consolidated financial statements.
6

Table of Contents
Maximus, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
For the Nine Months Ended
June 30, 2023June 30, 2022
(in thousands)
Cash flows from operating activities:
Net income$102,646 $134,761 
Adjustments to reconcile net income to cash flows from operations:
Depreciation and amortization of property, equipment, and capitalized software37,092 29,875 
Amortization of intangible assets70,599 67,951 
Amortization of debt issuance costs and debt discount2,236 1,946 
Deferred income taxes2,375 (7,179)
Stock compensation expense22,239 22,080 
Loss on sale of businesses883 — 
Change in assets and liabilities, net of effects of business combinations and disposals:
Accounts receivable7,675 (39,997)
Prepaid expenses and other current assets21,101 9,454 
Deferred contract costs2,245 (7,702)
Accounts payable and accrued liabilities16,915 (42,577)
Accrued compensation and benefits(31,612)13,846 
Deferred revenue(31,747)342 
Income taxes(33,186)(12,822)
Operating lease right-of-use assets and liabilities(3,742)(1,330)
Other assets and liabilities(15,968)1,128 
Net cash provided by operating activities169,751 169,776 
Cash flows from investing activities:
Purchases of property and equipment and capitalized software(58,863)(35,936)
Acquisitions of businesses, net of cash acquired— (14,144)
Proceeds from sale of businesses9,124 — 
Proceeds from sale of land and building— 2,000 
Net cash used in investing activities(49,739)(48,080)
Cash flows from financing activities:
Cash dividends paid to Maximus shareholders(51,053)(51,762)
Purchases of Maximus common stock— (73,864)
Tax withholding related to RSU vesting(8,475)(9,673)
Payments for contingent consideration(6,662)— 
Proceeds from borrowings682,398 415,000 
Principal payments for debt(730,514)(442,973)
Restricted cash movements(54,543)— 
Net cash used in financing activities(168,849)(163,272)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash3,735 (4,369)
Net change in cash, cash equivalents, and restricted cash(45,102)(45,945)
Cash, cash equivalents and restricted cash, beginning of period136,795 156,570 
Cash, cash equivalents and restricted cash, end of period$91,693 $110,625 
See accompanying notes to consolidated financial statements.
7

Table of Contents
Maximus, Inc.
Consolidated Statements of Changes in Shareholders' Equity
(Unaudited)

Common StockAccumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
Equity
SharesAmount
(in thousands)
Balance at September 30, 202260,774$557,978 $(33,961)$1,025,354 $1,549,371 
Net income— — 39,995 39,995 
Foreign currency translation— 8,036 — 8,036 
Cash flow hedge, net of tax— (3,781)— (3,781)
Cash dividends— — (17,017)(17,017)
Dividends on RSUs298 — (298)— 
Stock compensation expense4,403 — — 4,403 
Balance as of December 31, 202260,774$562,679 $(29,706)$1,048,034 $1,581,007 
Net income— — 31,788 31,788 
Foreign currency translation— 965 — 965 
Cash flow hedge, net of tax— (4,562)— (4,562)
Cash dividends— — (17,016)(17,016)
Dividends on RSUs413 — (413)— 
Stock compensation expense9,540 — — 9,540 
RSUs vested10— — — — 
Balance as of March 31, 202360,784$572,632 $(33,303)$1,062,393 $1,601,722 
Net income— — 30,863 30,863 
Foreign currency translation— 1,946 — 1,946 
Cash flow hedge, net of tax— 7,046 — 7,046 
Cash dividends— — (17,020)(17,020)
Dividends on RSUs410 — (410)— 
Stock compensation expense8,296 — — 8,296 
Balance as of June 30, 202360,784$581,338 $(24,311)$1,075,826 $1,632,853 












8

Table of Contents
Maximus, Inc.
Consolidated Statements of Changes in Shareholders' Equity
(Unaudited)

Common StockAccumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
Equity
SharesAmount
(in thousands)
Balance at September 30, 202161,954$532,411 $(39,908)$987,826 $1,480,329 
Net income— — 53,330 53,330 
Foreign currency translation— 459 — 459 
Cash flow hedge, net of tax— 2,685 — 2,685 
Cash dividends— — (17,347)(17,347)
Dividends on RSUs272 — (272)— 
Purchases of Maximus common stock(18)— — (1,379)(1,379)
Stock compensation expense8,248 — — 8,248 
Tax withholding adjustment related to RSU vesting2,101 — — 2,101 
Balance as of December 31, 202161,936$543,032 $(36,764)$1,022,158 $1,528,426 
Net income— — 50,096 50,096 
Foreign currency translation— (23)— (23)
Cash flow hedge, net of tax— 10,689 — 10,689 
Cash dividends— — (17,312)(17,312)
Dividends on RSUs392 — (392)— 
Purchases of Maximus common stock(330)— — (24,464)(24,464)
Stock compensation expense6,804 — — 6,804 
RSUs vested4— — — — 
Balance as of March 31, 202261,610$550,228 $(26,098)$1,030,086 $1,554,216 
Net income— — 31,335 31,335 
Foreign currency translation— (8,935)— (8,935)
Cash flow hedge, net of tax— 3,042 — 3,042 
Cash dividends— — (17,103)(17,103)
Dividends on RSUs400 — (400)— 
Purchases of Maximus common stock(706)— — (48,021)(48,021)
Stock compensation expense7,028 — — 7,028 
Balance as of June 30, 202260,904$557,656 $(31,991)$995,897 $1,521,562 
See accompanying notes to consolidated financial statements.
9

Table of Contents
Maximus, Inc.
Notes to the Consolidated Financial Statements
1. ORGANIZATION
Maximus, a Virginia corporation established in 1975, is a leading operator of government health and human services programs and provider of technology solutions to governments. Under our mission of Moving People Forward, we offer industry-leading expertise, including citizen engagement, eligibility and program integrity, independent clinical assessments, case management, and technology modernization services to enable citizens around the globe to successfully engage with their governments at all levels. We are a proud partner to government agencies in the United States, Australia, Canada, Italy, Saudi Arabia, Singapore, South Korea, United Arab Emirates, and the United Kingdom.

2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements, including the notes, include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). All intercompany balances and transactions have been eliminated in consolidation.
Basis of Presentation for Interim Periods
Certain information and footnote disclosures normally included for the annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. We believe that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations and cash flows for the periods presented.
The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended September 30, 2022 included in our Annual Report on Form 10-K for the fiscal year then ended (the "2022 10-K"). We have continued to follow the accounting policies set forth in those financial statements.
Use of Estimates
The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation.
In May 2021, we acquired VES Group, Inc. As part of the acquisition, we allocated a valuation of $27 million to certain technology assets used by the business, which we elected to amortize over twelve years, which was our best estimate of asset life at that time. In fiscal year 2023, we have taken the opportunity to improve our technology portfolio, including the development of technology, which will eventually replace much of the acquired technology. Accordingly, we have revised the asset life on the existing technology assuming the assets will cease being used by September 2026. This change in estimated useful life will result in additional annual amortization expense of $3.8 million per year. In the three and nine months ended June 30, 2023, this change reduced our diluted earnings per share by approximately $0.01 and $0.03, respectively.
In June 2023, we recorded an expense of $22.1 million for our best estimate of the investigation and remediation costs of a cybersecurity incident, reducing diluted earnings per share by approximately $0.26 for the three and nine months ended June 30, 2023, respectively. The estimated impact and expense is based on information currently available and the actual impact and expense may be greater than our estimates.


10

Table of Contents
3. BUSINESS SEGMENTS
We conduct our operations through three business segments: U.S. Federal Services, U.S. Services, and Outside the U.S.
U.S. Federal Services
Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage which continues to be managed within this segment. Under Technology Consulting Services, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions through Veterans Evaluation Services (VES), a Maximus company, which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs.
U.S. Services
Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Over the last three years, many programs in this segment have been operating with depressed margins resulting from the pause in Medicaid redeterminations. The depressed margins have resulted from reduced operating leverage in the segment as costs cannot scale down at the same rate to meet lower demand due to requirement to fulfill other obligations on these contracts. With the resumption of redeterminations, we expect a full period of volumes coming back into these programs and which enables our operating leverage to recover. A temporary offset to the depressed margins from paused redeterminations was the government's COVID-19 response efforts in prior fiscal years. The segment supported contact tracing, disease investigation, and vaccine distribution support services which concluded in fiscal year 2022. The segment also successfully expanded into the unemployment insurance market where longer term opportunities have materialized. As part of the broader strategy to evolve clinically and address societal macro trends such as aging populations and rising costs, the segment continues to expand its offerings in public health with new work in in-person assessments.
Outside the U.S.
Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS") and the recently awarded replacement contract to start in 2024, Functional Assessment Services (“FAS”), and Restart; Australia, including Workforce Australia and the Disability Employment Service; Canada, including the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, and UAE where we predominantly provide employment support and job seeker services.
11

Table of Contents
Table 3: Results of Operation by Business Segment
 For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
Amount% (1)Amount% (1)Amount% (1)Amount% (1)
(dollars in thousands)
Revenue:    
U.S. Federal Services$583,960 $525,519 $1,786,202 $1,680,678 
U.S. Services449,061 399,320 1,338,242 1,183,814 
Outside the U.S.155,656 200,946 520,331 589,495 
Revenue$1,188,677 $1,125,785 $3,644,775 $3,453,987 
Gross profit:
U.S. Federal Services$156,945 26.9 %$124,203 23.6 %$402,513 22.5 %$365,932 21.8 %
U.S. Services98,538 21.9 %74,135 18.6 %268,152 20.0 %248,805 21.0 %
Outside the U.S.8,881 5.7 %11,883 5.9 %67,049 12.9 %52,090 8.8 %
Gross profit$264,364 22.2 %$210,221 18.7 %$737,714 20.2 %$666,827 19.3 %
Selling, general, and administrative expenses: 
U.S. Federal Services$82,892 14.2 %$69,466 13.2 %$229,591 12.9 %$203,340 12.1 %
U.S. Services51,536 11.5 %42,351 10.6 %140,793 10.5 %115,726 9.8 %
Outside the U.S.24,122 15.5 %23,101 11.5 %75,936 14.6 %68,452 11.6 %
Loss on sale of businesses (2)— NM— NM883 NM— NM
Other (3)23,995 NM(1,944)NM24,242 NM(16)NM
Selling, general, and administrative expenses$182,545 15.4 %$132,974 11.8 %$471,445 12.9 %$387,502 11.2 %
Operating income/(loss): 
U.S. Federal Services$74,053 12.7 %$54,737 10.4 %$172,922 9.7 %$162,592 9.7 %
U.S. Services47,002 10.5 %31,784 8.0 %127,359 9.5 %133,079 11.2 %
Outside the U.S.(15,241)(9.8)%(11,218)(5.6)%(8,887)(1.7)%(16,362)(2.8)%
Amortization of intangible assets(23,431)NM(22,690)NM(70,599)NM(67,951)NM
Loss on sale of businesses (2)— NM— NM(883)NM— NM
Other (3)(23,995)NM1,944 NM(24,242)NM16 NM
Operating income$58,388 4.9 %$54,557 4.8 %$195,670 5.4 %$211,374 6.1 %
(1)Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM."
(2)During the second quarter of fiscal year 2023, we sold a small commercial practice in the United Kingdom and our employment operations business in Sweden, both subsidiaries within our Outside the U.S. Segment, resulting in a loss. Refer to "Note 7. Divestitures" for more details.
(3)Other includes credits and costs that are not allocated to a particular segment. In the three and nine months ended June 30, 2023, these charges include $22.1 million related to the costs of a previously disclosed cybersecurity incident. Other charges include those related to acquisitions.
12

Table of Contents
4. REVENUE RECOGNITION
We recognize revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations that are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customers that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services.
Disaggregation of Revenue
In addition to our segment reporting, we disaggregate our revenues by contract type and customer type. Our operating segments represent the manner in which our Chief Executive Officer reviews our financial results, which is further discussed in "Note 3. Business Segments."
Table 4.1: Revenue by Contract Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands)
Performance-based$617,800 52.0 %$520,202 46.2 %$1,761,764 48.3 %$1,527,368 44.2 %
Cost-plus281,014 23.6 %282,578 25.1 %940,509 25.8 %945,482 27.4 %
Fixed price171,809 14.5 %160,219 14.2 %527,556 14.5 %470,591 13.6 %
Time and materials118,054 9.9 %162,786 14.5 %414,946 11.4 %510,546 14.8 %
Total revenue$1,188,677 $1,125,785 $3,644,775 $3,453,987 
Table 4.2: Revenue by Customer Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands)
U.S. federal government agencies$568,924 47.9 %$507,047 45.0 %$1,742,739 47.8 %$1,624,848 47.0 %
U.S. state government agencies445,855 37.5 %401,042 35.7 %1,329,766 36.5 %1,183,876 34.3 %
International government agencies148,742 12.5 %191,753 17.0 %491,861 13.5 %557,928 16.2 %
Other, including local municipalities and commercial customers25,156 2.1 %25,943 2.3 %80,409 2.2 %87,335 2.5 %
Total revenue$1,188,677 $1,125,785 $3,644,775 $3,453,987 
Contract balances
Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue.
In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month and such balances are considered collectible and are included within accounts receivable, net.
Exceptions to this pattern will arise for various reasons, including those listed below.
Under cost-plus contracts, we are typically required to estimate a contract's share of our general and administrative expenses. This share is based upon estimates of total costs, which may vary over time. We typically invoice our customers at an agreed provisional billing rate which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability.
13

Table of Contents
Certain contracts include retainage balances, whereby revenue is earned, but some portion of cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable - unbilled until restrictions on billing are lifted. As of June 30, 2023 and September 30, 2022, $13.7 million and $13.1 million, respectively, of our unbilled receivables related to amounts pursuant to contractual retainage provisions.
In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as "set-up costs" and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation that is distinct from the service that is subsequently provided and, as a result, revenue is not recognized based upon the establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred.
Some of our contracts, notably our employment services contracts in the Outside the U.S. Segment, include payments for desired outcomes, such as job placement and job retention, and these outcome payments occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery.
During the three and nine months ended June 30, 2023, we recognized revenue of $13.9 million and $75.3 million, respectively, included in our deferred revenue balances at September 30, 2022. During the three and nine months ended June 30, 2022, we recognized revenue of $23.7 million and $85.5 million, respectively, included in our deferred revenue balances at September 30, 2021.
Contract estimates
We are required to use estimates in recognizing revenue from some of our contracts.
Some of our performance-based contract revenue is recognized based upon future milestones defined in each contract. This is the case in many of our employment services contracts in the Outside the U.S. Segment, where we are paid as individuals attain employment milestones, which may take many months to achieve. We recognize revenue over the period of performance. Our estimates vary from contract to contract but may include the number of participants within a portfolio reaching employment milestones and the service delivery periods for participants reaching the employment milestone.
We estimate the total variable fees we will receive using the expected value method. We recognize the fees over the expected period of performance. At each reporting period, we update our estimates of the variable fees to represent the circumstances present at the end of the reporting period. We are required to constrain our estimates to the extent that it is probable that there will not be a significant reversal of cumulative revenue when the uncertainty is resolved. We do not have a history of significant constraints on these contracts.
Table 4.3: Effect of Changes in Contract Estimates
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(in thousands, except per share data)
Benefit to/(reduction of) revenue recognized due to changes in contract estimates$(2,134)$(959)$(8,272)$(5,174)
Benefit to/(reduction of) diluted earnings per share recognized due to changes in contract estimates$(0.03)$(0.01)$(0.09)$(0.06)
Remaining performance obligations
As of June 30, 2023, we had approximately $350 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 65% of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration which is allocated entirely to future performance obligations, including variable transaction fees or fees tied directly to costs incurred.
14

Table of Contents
5. EARNINGS PER SHARE
Table 5: Weighted Average Number of Shares - Earnings Per Share
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(in thousands)
Basic weighted average shares outstanding61,141 61,607 61,125 62,038 
Dilutive effect of unvested RSUs and PSUs403 149 243 152 
Denominator for diluted earnings per share61,544 61,756 61,368 62,190 
The diluted earnings per share calculation for the three and nine months ended June 30, 2023 excludes approximately 98,000 and 105,000 unvested anti-dilutive restricted stock units, respectively. For the three and nine months ended June 30, 2022, approximately 418,000 and 178,000 unvested anti-dilutive restricted stock units were excluded from the diluted earnings per share calculation, respectively.

6. DEBT AND DERIVATIVES
Table 6.1: Details of Debt
June 30, 2023September 30, 2022
(in thousands)
Term Loan A, due 2026$930,000 $971,250 
Term Loan B, due 2028345,850 395,000 
Revolver39,000 — 
Subsidiary loan agreements3,321 64 
Funded Debt1,318,171 1,366,314 
Less: Unamortized debt-issuance costs and discounts(8,137)(10,373)
Total debt1,310,034 1,355,941 
Less: Current portion of long-term debt(86,901)(63,458)
Long-term debt$1,223,133 $1,292,483 
We entered into a credit agreement with JPMorgan Chase Bank, N.A. in May 2021 comprised of Term Loan A, Term Loan B, and a $600.0 million revolving credit facility ("Revolver"). During the first quarter of fiscal year 2023, we converted our interest rate index from the London Interbank Overnight Rate ("LIBOR") to the Secured Overnight Financing Rate ("SOFR").
The Credit Agreement requires us to comply with a number of covenants, including leverage and interest coverage ratios. At June 30, 2023, we are in compliance with all covenants. We do not believe that the covenants represent a significant restriction on our ability to successfully operate the business or to pay dividends.
In addition to the corporate Credit Agreement, we hold smaller credit facilities in Australia, Canada, and the United Kingdom. These allow our businesses to borrow funds to meet any short-term working capital needs.
The following table sets forth future minimum principal payments due under our debt obligations as of June 30, 2023 for the remainder of fiscal year 2023 through fiscal year 2027 and thereafter:
15

Table of Contents
Table 6.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
July 1, 2023 through September 30, 2023$24,817 
Year ended September 30, 202485,985 
Year ended September 30, 202592,860 
Year ended September 30, 2026779,984 
Year ended September 30, 20273,485 
Thereafter331,040 
Total Payments$1,318,171 
Interest Rate Derivative Instruments
To reduce our interest rate risk, we entered into interest-rate swap agreements covering our Term Loan A, effectively setting a fixed rate for a portion of our debt. At June 30, 2023, we have arrangements in place that fix our interest rate of $500 million through May 2026 and a further arrangement to fix $150 million through September 2024. The balance of the debt pays interest based upon an index. The floating interest rate on these instruments was converted from LIBOR to SOFR in December 2022, concurrent with our debt agreements. In converting our debt and interest-rate swaps, we utilized the practical expedients allowed under ASU No. 2020-04 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which allowed us to treat these amendments as though the modification was not substantial. At June 30, 2023, our effective interest rate, including the original issuance costs and discount rate, was 5.9%.
Our interest-rate swap agreements are valued quarterly and recorded on our balance sheet. As of June 30, 2023, we had assets of $29.7 million, compared to an asset of $31.4 million as of September 30, 2022. These balances were recorded in "other assets" on our consolidated balance sheet. As these hedges are considered effective, all gains and losses are reported within other comprehensive income on our consolidated statement of comprehensive income.

7. DIVESTITURES
On March 6, 2023, we sold a small commercial practice in the United Kingdom, part of our Outside the U.S. Segment, resulting in a pre-tax loss of $0.6 million. The cash consideration will be received in installments, with a fair value of $16.0 million. The installment payments are unconditional.
On March 30, 2023, we sold our Swedish subsidiary for cash consideration of $0.4 million, resulting in a small loss.

8. FAIR VALUE MEASUREMENTS
The following assets and liabilities are recorded at fair value on a recurring basis.
We hold mutual fund assets within a Rabbi Trust to cover liabilities in our deferred compensation plan. These assets have prices quoted within active markets and, accordingly, are classified as level 1 within the fair value hierarchy.
We have three interest rate swap agreements, serving to reduce our interest rate risk on our debt. These assets and liabilities can be valued using observable data and, accordingly, are classified as level 2 within the fair value hierarchy.
We anticipate paying additional consideration for certain acquisitions based upon the subsequent performance of the businesses acquired. This liability is based upon our internal assumptions over revenues, margins, volumes, and contract terms. Accordingly, these inputs are not observable and are classified as level 3 within the fair value hierarchy.
We will receive payments from the sale of a small commercial practice in the United Kingdom over the next three years. We have discounted the asset based upon our cost of capital, which is not an observable input. The balance at the sale of the business was $6.8 million. These assets are held in "Prepaid expenses and other current assets" and "Other assets" on our consolidated balance sheet.
16

Table of Contents
The tables below present assets and liabilities measured and recorded at fair value in our consolidated balance sheets on a recurring basis and their corresponding level within the fair value hierarchy. No transfers between Level 1, Level 2, and Level 3 fair value measurements occurred for the nine months ended June 30, 2023.
Table 8.1: Fair Value Measurements
As of June 30, 2023
Level 1Level 2Level 3Balance
(in thousands)
Assets:
Deferred compensation assets - Rabbi Trust$27,306 $— $— $27,306 
Interest rate swaps - $650 million notional value
— 29,647 — 29,647 
Notes receivable— — 7,397 7,397 
Total assets$27,306 $29,647 $7,397 $64,350 
Liabilities:
Contingent consideration— — 12,700 12,700 
Total liabilities$— $— $12,700 $12,700 
The fair values of receivables, prepaids, other assets, accounts payable, accrued costs, and other current liabilities approximate the carrying values as a result of the short-term nature of these instruments. The carrying value of our debt is consistent with the fair value as the stated interest rates in the agreements are consistent with the current market rates used in notes with similar terms in the markets (Level 2 inputs).
Accumulated Other Comprehensive Loss
All amounts recorded in accumulated other comprehensive loss are related to our foreign currency translations and interest rate swap, net of tax. The following table shows changes in accumulated other comprehensive loss:
Table 8.2: Details of Changes in Accumulated Other Comprehensive Loss by Category
Foreign currency translation adjustmentNet unrealized gain on derivatives, net of taxTotal
(in thousands)
Balance as of September 30, 2022$(57,109)$23,148 $(33,961)
Other comprehensive income before reclassifications10,831 4,554 15,385 
Amounts reclassified from accumulated other comprehensive loss116 (5,851)(5,735)
Net current period other comprehensive losses10,947 (1,297)9,650 
Balance as of June 30, 2023$(46,162)$21,851 $(24,311)
Contingent Consideration
The fair value of our contingent considerations are based upon estimates of the likely payments, which are based upon assumptions over future performance. The liabilities are reviewed on a quarterly basis and, where changes in estimates arise, these are recorded to selling and general administrative expenses.
Our contingent consideration relates to the businesses below:
In October 2021, we acquired the student loan servicing business from Navient, rebranded as Aidvantage. Future payments are based upon volumes, up to a maximum payment of $65.0 million. At June 30, 2023 and September 30, 2022, the Aidvantage contingent consideration was $10.2 million and $13.8 million, respectively.
In January 2022, we acquired BZ Bodies Limited. Future payments are based upon the performance of the business through December 2023, up to a maximum payment of $2.5 million (£2.0 million British Pounds). At June 30, 2023 and September 30, 2022, we recorded a contingent consideration liability for the maximum payment, which we anticipate making in fiscal year 2024.
In December 2015, we acquired companies doing business as Assessments Australia. Future payments were based upon future revenue earnings. The deadline for the payment expired on December 31, 2022, with no payment being required.
17

Table of Contents
Movement in our contingent consideration balance is as follows:
Table 8.3: Fair Value Measurement Using Significant Unobservable Inputs (Level 3)
Contingent Consideration
(in thousands)
Opening contingent consideration as of September 30, 2022$16,236 
Adjustments to fair value recorded in the period2,810 
Cash payments(6,662)
Foreign currency translations316 
Closing contingent consideration as of June 30, 2023$12,700 

9. EQUITY
Stock Compensation
We grant restricted stock units ("RSUs") and performance stock units ("PSUs") to eligible participants under our 2021 Omnibus Incentive Plan, which was approved by the Board of Directors and stockholders. The RSUs granted to employees vest ratably over service periods of three to five years and one year for members of the board of directors, in each case from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions and the number of PSUs earned could vary from 0% to 200% of the number of PSUs awarded. The PSUs will vest at the end of a three year-performance period. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant.
During the nine months ended June 30, 2023, we issued approximately 337,000 RSUs, which will vest ratably over one to four years, and approximately 137,000 PSUs, which will vest after three years.

10. OTHER BALANCE SHEET ITEMS
Cash, Cash Equivalents, and Restricted Cash
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2023September 30, 2022
(in thousands)
Cash and cash equivalents$35,007 $40,658 
Restricted cash56,686 96,137 
Cash, cash equivalents, and restricted cash$91,693 $136,795 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets. At September 30, 2022, this balance included $60.7 million of funds received from a customer which had previously been sold under our Receivables Purchase Agreement; this is offset by a corresponding liability in "Other current liabilities". No similar arrangements existed at June 30, 2023. The remaining balance includes funds held in trust on behalf of certain clients, offset with a corresponding liability in "Other current liabilities", and certain collateral obligations on contracts.
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Nine Months Ended
June 30, 2023June 30, 2022
(in thousands)
Interest payments$59,580 $28,251 
Income tax payments$60,460 $64,057 
18

Table of Contents
Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
June 30, 2023September 30, 2022
(in thousands)
Billed and billable receivables$683,180 $723,979 
Unbilled receivables120,097 91,404 
Allowance for credit losses(4,768)(8,273)
Accounts receivable, net$798,509 $807,110 
In September 2022, we entered into a Receivables Purchase Agreement with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable balances up to a maximum amount of $200.0 million at any given time. In return for these sales, we receive a cash payment equal to the face value of the receivables less a financing charge.
We account for these transfers as sales. We have no retained interest in the transferred receivables other than administrative responsibilities, and Wells Fargo has no recourse for any credit risk. We estimate that the implicit servicing fees for an arrangement of this size and type would be immaterial.
For the nine months ended June 30, 2023, the gross fair value of accounts receivable transferred to Wells Fargo and derecognized from our balance sheet was $378.4 million. In exchange for these sales, we received $376.3 million in cash. The balance, representing a loss on sale from these transfers, is included within our selling, general and administrative expenses. We have recorded these transactions within our operating cash flows. The effective annual interest rate under this program was 5.2%.

11. COMMITMENTS AND CONTINGENCIES
Litigation
We are subject to audits, investigations, and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of federal, state, local, and foreign governments, and otherwise in connection with performing services in countries outside of the U.S. Adverse findings could lead to criminal, civil, or administrative proceedings, and we could be faced with penalties, fines, suspension, or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local, and foreign governments for taxes. We are also involved in various claims, arbitrations, and lawsuits arising in the normal conduct of our business. These include but are not limited to bid protests, employment matters, contractual disputes, and charges before administrative agencies. Although we can give no assurance, based upon our evaluation and taking into account the advice of legal counsel, we do not believe that the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
We evaluate, on a regular basis, developments in our litigation matters and establish or make adjustments to our accruals as appropriate. A liability is accrued if a loss is probable and the amount of such loss can be reasonably estimated. If the risk of loss is probable, but the amount cannot be reasonably estimated, or the risk of loss is only reasonably possible, a liability is not accrued. Due to the inherent uncertainty in the outcome of litigation, our estimates and assessments may prove to be incomplete or inaccurate and could be impacted by unanticipated events and circumstances, adverse outcomes or other future determinations.
MOVEit Cybersecurity Incident Litigation
As the Company has previously disclosed, on May 31, 2023 Progress Software Corporation, the developer of MOVEit (“MOVEit”), a file transfer application used by many organizations to transfer data, announced a critical zero-day vulnerability in the application that allowed unauthorized third parties to access its customers’ MOVEit environments. It appears that a significant number of commercial and government customers worldwide were affected by this vulnerability. Maximus uses MOVEit for internal and external file sharing purposes, including to share data with government customers pertaining to individuals who participate in various government programs. The Company believes that the personal information of a significant number of individuals was accessed by an unauthorized third party by exploiting this MOVEit vulnerability.
19

Table of Contents
On August 1, 2023, a purported class action was filed against Maximus Federal Services, Inc. (a wholly-owned subsidiary of Maximus, Inc.) in the U.S. District Court for the Eastern District of Virginia arising out of the MOVEit cybersecurity incident – Bishop v. Maximus Federal Services, Case No. 1:23-cv-01019 (U.S. Dist. Ct. E. D. VA). The plaintiff, who purports to represent a nationwide class of individuals, alleges, among other things, that the Company’s negligence resulted in the compromise of the plaintiff’s personally identifiable Information and protected health information. The plaintiff seeks damages to be proved at trial. The Company is not able to determine or predict the ultimate outcome of this proceeding or reasonably provide an estimate or range of the possible outcome or loss if any.
On August 2, 2023, a purported class action was filed against Maximus, Inc. and Maximus Federal Services, Inc. in the U.S. District Court for the Eastern District of Virginia arising out of the MOVEit cybersecurity incident – Buzzell v. Maximus, Case No. 1:23-cv-01028 (U.S. Dist. Ct. E. D. VA). The plaintiff, who purports to represent a nationwide class of individuals, alleges, among other things, that the Company’s negligence resulted in the compromise of the plaintiff’s personally identifiable Information and protected health information. The plaintiff seeks damages to be proved at trial. The Company is not able to determine or predict the ultimate outcome of this proceeding or reasonably provide an estimate or range of the possible outcome or loss if any.

12. SUBSEQUENT EVENT
On July 7, 2023, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on August 31, 2023, to shareholders of record on August 15, 2023. Based on the number of shares outstanding, we anticipate a cash payment of approximately $17.0 million.
20

Table of Contents
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our financial statements and related notes in Item 1 and in the 'Special Note Regarding Forward-Looking Statements' in this Quarterly Report on Form 10-Q and the audited financial statements and related notes, risk factors and Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for fiscal year 2022 filed with the Securities and Exchange Commission on November 22, 2022.
Business Overview
We are a global company with approximately 39,500 employees and 12,550 contingent workers dedicated to helping governments on four continents to administer their citizen-facing programs. Under our mission of Moving People Forward, we offer industry-leading expertise, including citizen engagement, eligibility and program integrity, independent clinical assessments and case management, and technology modernization services to enable citizens around the globe to successfully engage with their governments at all levels. We are instrumental in helping people who need governmental support get it.
Over the past five years, we have executed a three-pronged growth strategy: we have evolved through our digital transformation to meet the modernization needs of our clients; we have expanded our clinical assessment capabilities to meet growing demand for independent and conflict-free clinical services; and we have expanded our markets, both organically and through acquisitions.
In fiscal year 2022, we refreshed our strategy and updated the three pillars on which we will focus growth efforts for the next three to five years:
Customer Services, Digitally Enabled. We apply proven technologies, data, and best practices to make government programs more customer-focused, effective, and deserving of the public's trust. We make it easier for people to connect to government services based on their individual preferences and abilities. We are elevating the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing.
Future of Health. We are expanding our clinical-related services and are experienced in delivering clinical BPS services at scale. We have established an extensive set of services that frequently requires a network of healthcare professionals who can complete clinical assessments, provide occupational health and independent medical review services, and adjudicate complicated benefits appeals.
Advanced Technologies for Modernization. We are furthering our credibility as a technology leader, enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable. Leveraging our deep relationships and program knowledge, we are delivering technology-driven business transformation of government missions with a strategic near-term focus on hybrid cloud solutions, information intelligence, and hyper-automation.

21

Table of Contents
Financial Overview
A number of factors have affected our results for the third quarter of fiscal year 2023, the most significant of which we have listed below. More detail on these changes is presented below within our "Results of Operations" section.
Our results in the third quarter of fiscal year 2023 include a $22.1 million expense for our best estimate of the investigation and remediation costs of a previously disclosed cybersecurity incident. As previously disclosed, the Company believes that the personal information of a significant number of individuals was accessed by an unauthorized third party by exploiting a vulnerability in a file transfer application used by the Company for internal and external file sharing purposes. Based on the review of impacted files to date, the Company believes those files contain personal information, including social security numbers, protected health information and/or other personal information, of at least 14.5 to 17.5 million individuals to whom the Company anticipates providing notice of the incident. The estimated number of impacted individuals and estimated expenses is based on currently available information and the actual number of impacted individuals or actual costs incurred could be greater than our estimates.
Our SG&A cost base has expanded with the growth of the business, including investments in our workforce and business infrastructure.
Our international business results have been tempered by the strength of the U.S. Dollar against the other currencies in which we operate.
The cost of financing our debt has increased year-over-year as interest rates have increased.

Results of Operations
The following table sets forth items from our consolidated statements of operations for the three months and nine months ended June 30, 2023 and June 30, 2022.
Table MD&A 1: Consolidated Results of Operations
 For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands, except per share data)
Revenue$1,188,677 $1,125,785 $3,644,775 $3,453,987 
Cost of revenue924,313 915,564 2,907,061 2,787,160 
Gross profit264,364 210,221 737,714 666,827 
Gross profit percentage22.2 %18.7 %20.2 %19.3 %
Selling, general, and administrative expenses182,545 132,974 471,445 387,502 
Selling, general, and administrative expenses as a percentage of revenue15.4 %11.8 %12.9 %11.2 %
Amortization of intangible assets23,431 22,690 70,599 67,951 
Operating income58,388 54,557 195,670 211,374 
Operating margin4.9 %4.8 %5.4 %6.1 %
Interest expense21,026 10,791 63,631 29,867 
Other expense/(income), net1,005 2,497 (79)2,093 
Income before income taxes36,357 41,269 132,118 179,414 
Provision for income taxes5,494 9,934 29,472 44,653 
Effective tax rate15.1 %24.1 %22.3 %24.9 %
Net income$30,863 $31,335 $102,646 $134,761 
Earnings per share:
Basic$0.50 $0.51 $1.68 $2.17 
Diluted$0.50 $0.51 $1.67 $2.17 
22

Table of Contents
Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.
Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2023
RevenueCost of RevenueGross Profit
Dollars% ChangeDollars% ChangeDollars% Change
(dollars in thousands)
Three Months Ended June 30, 2022$1,125,785 $915,564 $210,221 
Organic effect74,912 6.7  %21,393 2.3  %53,519 25.5  %
Disposal of businesses(9,097)(0.8)%(9,474)(1.0)%377 0.2 %
Acquired growth731 0.1  %354 —  %377 0.2  %
Currency effect compared to the prior period(3,654)(0.3) %(3,524)(0.4) %(130)(0.1) %
Three Months Ended June 30, 2023$1,188,677 5.6  %$924,313 1.0  %$264,364 25.8  %
Table MD&A 3: Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2023
 RevenueCost of RevenueGross Profit
Dollars% ChangeDollars% ChangeDollars% Change
(dollars in thousands)
Nine Months Ended June 30, 2022$3,453,987 $2,787,160 $666,827 
Organic effect239,575 6.9 %164,961 5.9 %74,614 11.2 %
Disposal of businesses(12,552)(0.4)%(12,817)(0.5)%265 — %
Acquired growth4,179 0.1 %2,297 0.1 %1,882 0.3 %
Currency effect compared to the prior period(40,414)(1.2)%(34,540)(1.2)%(5,874)(0.9)%
Nine Months Ended June 30, 2023$3,644,775 5.5 %$2,907,061 4.3 %$737,714 10.6 %
Selling, general, and administrative expenses ("SG&A")
Selling, general, and administrative expenses ("SG&A") consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.
Our SG&A expenses have expanded through our growth, as well as investments made in our workforce and infrastructure. In addition, our SG&A includes charges which are not directly connected to our day-to-day operations.
Our costs in the three and nine months ended June 30, 2023, include $22.1 million of estimated expenses for investigation and remediation activities related to the previously disclosed cybersecurity incident, including expenses for providing appropriate notifications to individuals affected by this incident and free credit monitoring and identity restoration services to such individuals.
We include costs related to our acquisitions within SG&A. Included within these costs in the three and nine months ended June 30, 2023 are $1.6 million and $2.9 million, respectively, related to increases in our anticipated consideration for our Aidvantage business, which we acquired in fiscal year 2022 for consideration based upon future performance.
Our SG&A expense for the nine months ended June 30, 2023 also includes losses of $0.8 million relating to the sale of two small businesses.


23

Table of Contents
Interest Expense
Interest expense for the three months ended June 30, 2022 and June 30, 2023, increased from $10.8 million to $21.0 million. Interest expense for the nine months ended June 30, 2022 and June 30, 2023 increased from $29.9 million to $63.6 million. These increases are principally due to market rate increases.
Our effective interest rate was 5.9% at June 30, 2023, compared to 3.4% at June 30, 2022. We have mitigated our risk by fixing interest rates on $650 million of our debt and our near term capital allocation plan continues to prioritize reducing our debt using our free cash flow. At our current debt balances, a 100 basis point change in SOFR would result in an increased annual interest expense of $6.7 million.
Provision for Income Taxes
Our effective income tax rate for the three and nine months ended June 30, 2023, was 15.1% and 22.3%, respectively, compared to 24.1% and 24.9% for the three and nine months ended June 30, 2022. Our effective income tax rate for the three months ended June 30, 2023 received discrete benefits from tax credits, as well as some benefits from U.S. state tax rates. For fiscal year 2023, we expect the effective tax rate to be between 23.0% and 23.5%.
U.S. Federal Services Segment
Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage which continues to be managed within this segment. Under Technology Consulting Services, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions through Veterans Evaluation Services (VES), a Maximus company, which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs.
Table MD&A 4: U.S. Federal Services Segment - Financial Results
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands)
Revenue$583,960 $525,519 $1,786,202 $1,680,678 
Cost of revenue427,015 401,316 1,383,689 1,314,746 
Gross profit156,945 124,203 402,513 365,932 
Selling, general, and administrative expenses82,892 69,466 229,591 203,340 
Operating income74,053 54,737 172,922 162,592 
Gross profit percentage26.9 %23.6 %22.5 %21.8 %
Operating margin percentage12.7 %10.4 %9.7 %9.7 %
Our revenue and cost of revenue for the three months ended June 30, 2023, increased 11.1% and 6.4%, respectively. For the nine months ended June 30, 2023, growth was 6.3% and 5.2%, respectively. All growth in fiscal year 2023 was organic.
Our U.S. Federal Services revenue and profit margins for the three months ended June 30, 2023 received the benefit of volume growth on the VES contracts.
Our results for the nine months ended June 30, 2023, received revenue growth from VES and Aidvantage. Profitability improvements from VES scaling were partially offset by our need to ramp-up staffing for VES during the early part of the year in anticipation of the current higher volumes.
We anticipate that our U.S. Federal Services business will continue to grow for the remainder of fiscal year 2023, driven primarily by additional volumes anticipated in the VES business. We anticipate full year operating margins will range between 10% and 11%.


24

Table of Contents
U.S. Services Segment
Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Over the last three years, many programs in this segment have been operating with depressed margins resulting from the pause in Medicaid redeterminations. The depressed margins have resulted from reduced operating leverage in the segment as costs cannot scale down at the same rate to meet lower demand due to requirement to fulfill other obligations on these contracts. With the resumption of redeterminations, we expect a full period of volumes coming back into these programs and which enables our operating leverage to recover. A temporary offset to the depressed margins from paused redeterminations was the government's COVID-19 response efforts in prior fiscal years. The segment supported contact tracing, disease investigation, and vaccine distribution support services which concluded in fiscal year 2022. The segment also successfully expanded into the unemployment insurance market where longer term opportunities have materialized. As part of the broader strategy to evolve clinically and address societal macro trends such as aging populations and rising costs, the segment continues to expand its offerings in public health with new work in in-person assessments.
Table MD&A 5: U.S. Services Segment - Financial Results
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands)
Revenue$449,061 $399,320 $1,338,242 $1,183,814 
Cost of revenue350,523 325,185 1,070,090 935,009 
Gross profit98,538 74,135 268,152 248,805 
Selling, general, and administrative expenses51,536 42,351 140,793 115,726 
Operating income47,002 31,784 127,359 133,079 
Gross profit percentage21.9 %18.6 %20.0 %21.0 %
Operating margin percentage10.5 %8.0 %9.5 %11.2 %
Our revenue and cost of revenue for the three months ended June 30, 2023, increased 12.5% and 7.8%, respectively, compared to the three months ended June 30, 2022. For the nine months ended June 30, 2023, our revenue and cost of revenue increased 13.0% and 14.4%, respectively, compared to the nine months ended June 30, 2022. All movement was organic and net of anticipated declines in short-term work related to the pandemic.
U.S. Services revenue and profitability in the three months ended June 30, 2023, has received the benefit of new work and Medicaid eligibility redetermination work commencing.
Our profit margins for the full fiscal year remain tempered, compared to fiscal year 2022, by the decline in higher-margin, pandemic related services.
This segment is expected to see the greater benefit from the resumption of Medicaid eligibility redeterminations. The nature and timing of the benefit is dependent on each states individual plans for the return of these services, but we continue to anticipate that services will have a greater contribution in the final quarter of the year. We anticipate a full year operating profit margin will be between 9% and 11%.
Outside the U.S. Segment
Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS") and the recently awarded replacement contract to start in 2024, Functional Assessment Services (“FAS”), and Restart; Australia, including Workforce Australia and the Disability Employment Service; Canada, including the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, and UAE where we predominantly provide employment support and job seeker services.
25

Table of Contents
Table MD&A 6: Outside the U.S. Segment - Financial Results
For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands)
Revenue$155,656 $200,946 $520,331 $589,495 
Cost of revenue146,775 189,063 453,282 537,405 
Gross profit8,881 11,883 67,049 52,090 
Selling, general, and administrative expenses24,122 23,101 75,936 68,452 
Operating loss(15,241)(11,218)(8,887)(16,362)
Gross profit percentage5.7 %5.9 %12.9 %8.8 %
Operating margin percentage(9.8) %(5.6) %(1.7) %(2.8) %
Table MD&A 7: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2023
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Three Months Ended June 30, 2022$200,946 $189,063 $11,883 
Organic effect(33,270)(16.6) %(29,644)(15.7) %(3,626)(30.5) %
Disposal of businesses(9,097)(4.5)%(9,474)(5.0)%377 3.2 %
Acquired growth731 0.4  %354 0.2  %377 3.2  %
Currency effect compared to the prior period(3,654)(1.8)%(3,524)(1.9)%(130)(1.1)%
Three Months Ended June 30, 2023$155,656 (22.5) %$146,775 (22.4) %$8,881 (25.3) %
Table MD&A 8: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2023
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Nine Months Ended June 30, 2022$589,495 $537,405 $52,090 
Organic effect(20,377)(3.5)%(39,063)(7.3)%18,686 35.9 %
Disposal of businesses(12,552)(2.1)%(12,817)(2.4)%265 0.5 %
Acquired growth4,179 0.7 %2,297 0.4 %1,882 3.6 %
Currency effect compared to the prior period(40,414)(6.9)%(34,540)(6.4)%(5,874)(11.3)%
Nine Months Ended June 30, 2023$520,331 (11.7)%$453,282 (15.7)%$67,049 28.7 %
Our results for the three and nine months ended June 30, 2023, were tempered by challenges within our welfare-to-work services, both at the macroeconomic level, where markets with low unemployment reduce the demand for our services, and at a contract level, where the reduction in scope of our Australian contract has reduced both revenue and profitability.
This segment also had revenue and margins tempered by slower ramping of a major new program, as well as challenges in achieving volumes in some of our employment programs as a result of low unemployment in our emerging markets.
In March 2023, we sold a small commercial practice in the United Kingdom and our employment operations in Sweden. Prospectively, we anticipate this will marginally improve our profit margins.
This segment also experienced declines in revenue and cost from currency movements, with the major currencies in which we do business declining year-over-year against the United States Dollar.
26

Table of Contents
Much of our revenue growth stems from our employment services contracts, where we are paid based upon our ability to place individuals in long-term sustained employment. We recognize revenue over our period of performance, using estimates of our ability to place people in work and the time that this will take can have significant effects on our revenue. Our estimates are based upon historical performance, where appropriate and available, and are constantly updated. This may result in volatility within revenue as changes in estimates of future performance impact the revenue recognized in any period.
We anticipate the segment will finish the year in a loss position. We are continuing our efforts to improve the performance of this segment. As we establish our plans for fiscal year 2024 and beyond, the actions we consider may result in additional charges, including impairment of assets.
Liquidity and Capital Resources
Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of June 30, 2023, we had $35.0 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be not only sufficient for our operating requirements but also to enable us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 6. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.
During the first nine months of fiscal year 2023, we entered into a number of debt-related transactions.
We entered into additional interest rate swaps, to bring the total balance of our credit facility subject to fixed rates to $650 million. This allows us greater opportunity to predict and manage our interest payments.
We amended both our debt and the corresponding interest rate swaps to use interest rates based upon the Secured Overnight Financing Rate (SOFR), replacing the previous LIBOR basis.
As part of the transition to SOFR, we took the opportunity to redeem some of our Term Loan B debt.
We have included the following table showing our debt balances as of June 30, 2023 and their effective interest rates.
Table MD&A 9: Balances and interest rates as of June 30, 2023
June 30, 2023
Carrying valueEffective cash interest rateInterest rate basis
(dollars in thousands)
Term Loan A - Unhedged$280,000 6.70%Term SOFR reset monthly plus margin. (1)
Term Loan A - Hedged though May 2026500,000 3.81%Fixed rate of 2.31% plus margin. (1)
Term Loan A - Hedged through September 2024150,000 5.98%Fixed rate of 4.48% plus margin. (1)
Term Loan B345,850 7.20%Term SOFR (variable reset) plus 2% margin.
Revolver39,000 6.69%Term SOFR reset monthly plus margin. (1)
Debt held by international subsidiaries3,321 5.48%Floating rate, reset quarterly.
Debt Principal$1,318,171 
(1) Applicable margin ranges between 1% and 2%, based on our leverage ratio.
Our effective cash interest rate reflects the drivers of our cash interest payments as of June 30, 2023, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of June 30, 2023 is 5.9%.






27

Table of Contents
The below table summarizes our change in cash, cash equivalents, and restricted cash.
Table MD&A 10: Net Change in Cash and Cash Equivalents and Restricted Cash
For the Nine Months Ended
June 30, 2023June 30, 2022
(in thousands)
Operating activities:
Net cash provided by operating activities$169,751 $169,776 
Net cash used in investing activities(49,739)(48,080)
Net cash used in financing activities(168,849)(163,272)
Effect of foreign exchange rates on cash and cash equivalents and restricted cash3,735 (4,369)
Net change in cash and cash equivalents and restricted cash$(45,102)$(45,945)
Net Cash Provided By Operating Activities
Net cash provided by operating activities was $169.8 million in the nine months of fiscal year 2023, which was consistent with the prior year notwithstanding the decline in net income. Our cash flows from operations received benefits from:
increased revenue and improved collections, with our DSO declining from 62 days to 61 days between September 30, 2022 and June 30, 2023; the corresponding movement in fiscal year 2022 was an increase of two days; and
the timing of certain cash payments, including a reduction in income tax payments.
These benefits were partially offset by increased interest payment on our debt and an additional payroll cycle in fiscal year 2023.
Net Cash Used In Investing Activities
Investing cash outflows in fiscal years 2023 and 2022 reflect acquisitions of property and equipment and investment in software. In fiscal year 2023, we received payments for the sale of our Swedish business and an installment payment on the sale of a small commercial practice in the United Kingdom.
Net Cash Used In Financing Activities
Net financing cash outflows reflect mandatory and early payments on our debt.
At September 30, 2022, our restricted cash balance was inflated by a large customer receivable of $60.7 million, which was paid to us after we had sold the balance to a third party, resulting in a financing cash inflow. During the period ended June 30, 2023, the payment was made and no similar timing differences existed as of June 30, 2023, resulting in a net cash outflow.
Credit Facilities
Our principal debt agreement is with JPMorgan Chase Bank N.A. (the Credit Agreement). At June 30, 2023, we owed $1.31 billion under the Credit Agreement, with access to an additional $561 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2028, when the agreement ends, and must be renegotiated or the funds repaid.
The Credit Agreement contains a number of covenants with which we are expected to comply. Failure to meet these requirements would result in a need to renegotiate the agreement or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement.
Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt, offset by up to $75 million of unrestricted cash (Consolidated Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step-up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.
28

Table of Contents
Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense, as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.
Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.
Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly-titled measures presented by other companies.
We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement which are included within our financial statements. At June 30, 2023, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction in our ability to operate our business or to pay our dividends.
Table MD&A 11: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement
For the Three
Months Ended
For the Trailing Twelve
Months Ended
June 30, 2023June 30, 2023
(in thousands)
Net income$30,863 $171,713 
Adjustments:
Interest expense21,026 79,729 
Other expense, net1,005 663 
Provision for income taxes5,494 58,089 
Amortization of intangibles23,431 93,113 
Stock compensation expense8,296 30,635 
Acquisition-related expenses1,587 2,909 
Gain on sale of land and building— (11,046)
Loss on sale of businesses— 883 
Depreciation and amortization of property, equipment, and capitalized software10,771 49,547 
Pro forma and other adjustments permitted by our Credit Agreement35,970 47,437 
Consolidated EBITDA (as defined by our Credit Agreement)$138,443 $523,672 
Table MD&A 12: Consolidated Net Total Leverage Ratio
For the Trailing Twelve
Months Ended
June 30, 2023
(in thousands, except ratio data)
Funded Debt (as defined by our Credit Agreement)$1,318,171 
Cash and cash equivalents up to $75 million35,007 
Consolidated Net Total Leverage (as defined by our Credit Agreement)$1,283,164 
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement)2.45 
29

Table of Contents
Table MD&A 13: Consolidated Net Interest Coverage Ratio
For the Trailing Twelve
Months Ended
June 30, 2023
(in thousands, except ratio data)
Consolidated EBITDA (as defined by our Credit Agreement)$523,672 
Interest expense79,729 
Components of other income/expense, net allowed in ratio calculation2,208 
Consolidated Net Interest Expense (as defined by our Credit Agreement)$81,937 
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement)6.39 
Cash in Foreign Locations
We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.
Free Cash Flow
Table MD&A 14: Free Cash Flow
For the Nine Months Ended
June 30, 2023June 30, 2022
(in thousands)
Net cash provided by operating activities$169,751 $169,776 
Purchases of property and equipment and capitalized software(58,863)(35,936)
Free cash flow$110,888 $133,840 

Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2022 Form 10-K, as filed with the SEC on November 22, 2022, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three or nine months ended June 30, 2023.

Non-GAAP and Other Measures
We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
30

Table of Contents
For the three months ended June 30, 2023, 13% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year.
In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results excluding transactions from acquisitions or disposals, to our prior fiscal year results.
Our recent acquisitions have resulted in significant intangible assets which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. Accordingly, we have calculated our operating profit, net income, and earnings per share, excluding the effect of the amortization of intangible assets. We have included the following table showing our reconciliation of these income measures to their corresponding U.S. GAAP measures.
Table MD&A 15: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets
 For the Three Months EndedFor the Nine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
(dollars in thousands, except per share data)
Operating income$58,388 $54,557 $195,670 $211,374 
Add back: Amortization of intangible assets23,431 22,690 70,599 67,951 
Adjusted operating income excluding amortization of intangible assets (Non-GAAP)$81,819 $77,247 $266,269 $279,325 
Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP)6.9 %6.9 %7.3 %8.1 %
Net income$30,863 $31,335 $102,646 $134,761 
Add back: Amortization of intangible assets, net of tax17,276 16,750 52,082 50,164 
Adjusted net income excluding amortization of intangible assets (Non-GAAP)$48,139 $48,085 $154,728 $184,925 
Diluted earnings per share$0.50 $0.51 $1.67 $2.17 
Add back: Effect of amortization of intangible assets on diluted earnings per share0.28 0.27 0.85 0.80 
Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP)$0.78 $0.78 $2.52 $2.97 
In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."
To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.
31

Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2022 Form 10-K, as filed with the SEC on November 22, 2022, have not changed materially during the nine month period ended June 30, 2023.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
32

Table of Contents
PART II - Other Information
Item 1. Legal Proceedings
Refer to our disclosures included in "Note 11. Commitments and Contingencies" included in Part 1, Item 1 of this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
Our systems and networks are and have been subject to cybersecurity breaches.
We are a trusted provider to government and other clients of critical health and human services that rely heavily upon technology systems, software, and networks to receive, input, maintain, and communicate participant and client data. The risk of a security breach, system disruption, ransom-ware attack, or similar cyber-attack or intrusion, including by computer hackers, cyber terrorists, or foreign governments, is persistent and substantial as the volume, intensity, and sophistication of attempted attacks, intrusions and threats from around the world increase daily. If our systems or networks are compromised, we could be adversely affected by losing confidential or protected information of program participants and clients or by facing a demand for ransom to restore access to such information. The loss, theft, or improper disclosure of that information could subject us to sanctions under the relevant laws, breach of contract claims, contract termination, class action, or individual lawsuits from affected parties, negative press articles, reputational damage, and a loss of confidence from our government clients, all of which could adversely affect our existing business, future opportunities, and financial condition. Additionally, if our internal networks were compromised, we could suffer the loss of proprietary, trade secret, or confidential technical and financial data. That could make us less competitive in the marketplace and adversely affect our existing business, future opportunities, and financial condition.
We have experienced cybersecurity incidents in the past which were immaterial, and in the third quarter of fiscal year 2023, we experienced a material cybersecurity incident as the personal information of a significant number of individuals was accessed by an unauthorized third party by exploiting a vulnerability in a file transfer application used by many organizations, including us. We have recorded expenses in connection with the investigation and remediation activities related to this incident but we are unable to predict other potential liabilities or consequences that may arise from this incident. Despite our remediation efforts, we may continue to experience cybersecurity incidents in the future.
Except as set forth above, there were no material changes during the nine months ended June 30, 2023, to the risk factors previously disclosed in the 2022 Form 10-K, as filed with the SEC on November 22, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a)None.
(b)None.
(c)None.
Item 3. Defaults Upon Senior Securities
(a)None.
(b)None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
(a)None.
(b)None.
(c)During the three months ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
33

Table of Contents
Item 6. Exhibits
Exhibit
No.
Description of Exhibit
v
v
Φ
Φ
101.INSvXBRL Instance Document.
101.SCHvXBRL Taxonomy Extension Schema Document.
101.CALvXBRL Taxonomy Calculation Linkbase Document.
101.DEFvXBRL Taxonomy Definition Linkbase Document.
101.LABvXBRL Taxonomy Label Linkbase Document.
101.PREvXBRL Taxonomy Presentation Linkbase Document.
104vCover Page Interactive Data File (formatted as Inline XBRL tags and contained in Exhibit 101).
vFiled herewith.
ΦFurnished herewith.
34

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Maximus, Inc.
/s/ Bruce L. CaswellAugust 3, 2023
By:Bruce L. Caswell
 President and Chief Executive Officer
 (Principal Executive Officer)
/s/ David W. MutrynAugust 3, 2023
By:David W. Mutryn
Chief Financial Officer
(Principal Financial Officer)
35